News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Patients progressing on 1L palbo should not receive further exposure to palbo- Paolo Tarantino
Photo: Paolo Tarantino/Twitter
Jun 10, 2023, 02:53

Patients progressing on 1L palbo should not receive further exposure to palbo- Paolo Tarantino

Consistent with the PACE trial, the PALMIRA randomized phase 2 trial showed no benefit in terms of PFS or OS with the use of palbociclib beyond progression to 1L ET+palbo. Patients progressing on 1L palbo should not receive further exposure to palbo. #ASCO23

Source: Paolo Tarantino/Twitter

ASCO23 palbo palbociclib Palmira Paolo Tarantino
Special Coverage
Blog
Apr 23, 2025, 17:17
Christian Ntizimira: Why does the African perspective in family meetings matter in oncology and palliative care?
Science
Apr 23, 2025, 17:13
International Consensus Statement on Diagnosis, Evaluation, and Research of Richter Transformation
Blog
Apr 23, 2025, 17:10
ESMO Living Guidelines for cutaneous melanoma
Blog
Apr 23, 2025, 17:03
City of Hope scientists and physicians will present their latest discoveries at the AACR Annual Meeting
Blog
Apr 23, 2025, 16:59
Michelle Mitchell: CRUK published report on UK-EU collaboration for global scientific research
Career
Apr 23, 2025, 16:51
Caryn Lerman: Yali Dou has been elected as a fellow of AAAS
Blog
Apr 23, 2025, 16:43
David Zaas: Proudly celebrated the ribbon-cutting of new Atrium Health Wake Forest Baptist Outpatient Surgery Center
Blog
Apr 23, 2025, 16:21
Alicia Zhou: Moderating CRI's dialogue on AI, data, and the future of cancer research
Blog
Apr 23, 2025, 16:21
Dolphins Cancer Challenge donates 100% of funds to Sylvester Comprehensive Cancer Center for cancer research
Blog
Apr 23, 2025, 16:12
The Spring 2025 edition of Oncolytics Today has arrived - NCODA
Blog
Apr 23, 2025, 16:07
Claudia Vasconcelos: DESTINY-Breast09 results could be practice-changing for patients with HER2+ MBC
Blog
Apr 23, 2025, 16:07
Suresh Ramalingam's work and Conquer Cancer's role in advancing cancer research